Table 2.
Characteristics of included studies on primary resection risk in Crohn’s Disease
Bernell et al,41 2000 | Sweden | Stockholm County | 1955 – 1989 | 1936 | All ages | M (47) F (53) |
- | - | 1, 5, and 10 |
Burr et al,9 2019 | UK | Research One | 1994 – 2013 | 3059 | All ages | M (47) F (53) |
- | - | 1, 5, and 10 |
Charpentier et al,17 2014 | France | EPIMAD | 1988 – 2006 | 367 | Elderly | M (38) F (62) |
- | B1 (78), B2 (17), B3 (5) | 1, 5, and 10 |
Chatu et al,42 2014 | UK | CPRD | 1989 – 2010 | 5640 | All ages | M (42) F (57) |
- | - | 5 |
Gheorge et al,21 2004 | Romania | 18 secondary and tertiary centers | 2002 – 2003 | 85 | Adults | M (57) F (43) |
L1 (15), L2 (52), L3 (32), L4 (2) | - | 1 |
Guasch et al,23 2018 | Spain | ENEIDA | 1990 – 1995, 2007 – 2012 | 7496 | All ages | - | - | - | 1 and 5 |
Jeuring et al,43 2015 | Netherlands | IBD-SL | 1991 – 2011 | 1159 | All ages | - | - | - | 1, 5, and 10 |
Lakatos et al,44 2012 | Hungary | Veszprem Province | 1977 – 2008 | 506 | All ages | M (49.6) F (50.4) |
L1 (32.8), L2 (36.0), L3 (30.6), L4 (0.6) | B1 (56.9), B2 (19.8), B3 (23.3) | 1, 5, and 10 |
Lirhus et al,27 2018 | Norway | Norwegian Patient Registry | 2010 – 2012 | 2829 | All Ages | M (47.5) F (52.5) |
- | - | 3 |
Nguyen et al,30 2017 | Canada | Ontario Province | 1999 – 2008 | 8985 | Adult | M (44.3) F (55.7) |
- | - | 5 and 10 |
Niewiadomski et al,31 2015 | Australia | Barwon Area | 2007 – 2008, 2010 – 2013 |
146 | All ages | - | - | - | 1 and 5 |
Nordenvall et al,32 2018 | Sweden | Swedish Patient Register | 2002 – 2014 | 2174 | Pediatric | M (58) F (42) |
- | - | 3 |
O’Keefe et al,45 1989 b | South Africa | Cape Town | 1970 – 1979 | 72 (5y), 53 (10y) |
All ages | - | - | - | 5 and 10 |
Pandey et al,46 2015 | Singapore | 8 hospitals | 1970 – 2013 | 430 | All ages | M (61.8) F (38.2) |
L1 (27.7), L2 (27.7), L3 (41.9), L4 (17.9) |
B1 (78.1), B2 (14.0), B3 (7.9) | 5 and 10 |
Peneau et al,47 2012 | France | EPIMAD | 1988 – 2004 | 538 | Pediatric | - | - | - | 1, 5, and 10 |
Peyrin-Biroulet et al,48 2012 | USA | Olmsted County | 1970 – 2004 | 310 | All ages | M (50.3) F (49.7) |
L1 (31.2), L2 (33.1), L3 (33.4), L4 (2.3) | B1 (81.3), B2 (4.6), B3 (14.1) | 5 and 10 |
Rabilloud et al,49 2016 | France | Brittany Area | 1994–1997 | 272 | All ages | - | - | - | 1, 5, and 10 |
Ramadas et al,50 2010 | UK | Cardiff | 1986 – 2003 | 341 | All ages | M (38) F (62) |
- | - | 1 and 5 |
Rungoe et al,11 2014 | Denmark | DNPR | 1979 – 2011 | 13185 | Adult | M (41) F (59) |
- | - | 1, 5, and 9 |
Solberg et al,51 2007 | Norway | IBSEN | 1990 – 1993 | 237 | All ages | M (50.2) F (49.8) |
L1 (27), L2 (48.5), L3 (22.8), L4 (1.7) | B1 (62.0), B2 (27.0), B3 (11.0) | 1, 5, and 10 |
Spizzo et al,39 2016 | Australia | GECCO | 2007 – 2015 | 62 | All ages | - | - | - | 4 |
Zhulina et al,52 2016 | Sweden | Orebro University Hospital | 1963 – 2005 | 472 | All ages | M (47) F (53) |
L1 (40.5), L2 (33.9), L3 (23.7), L4 (1.7) | B1 (63.5), B2 (19.5), B3 (16.7) | 1 and 5 |
M: Male, F: Female, L1: Ileal, L2: Colonic, L3: Ileocolonic, L4: Upper GI Tract, B1: Inflammatory, B2: Fibrostenotic, B3: Penetrating